$1.40
▼ -4.8% Today
as of Oct 22, 16:51 ET
Last 30 days
Recent Press Releases & News
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
RGNT earnings at a glance
The share price of $1.40 sits near its 52-week low.
Overview
52-week range
$1.23
$16
1% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for RGNT.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.